APA (7th ed.) Citation

JSY, M., PC, E., C, I., & LJ, F. (2026). The role of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors in chronic obstructive pulmonary disease. Expert review of clinical immunology, 22(1), 31. https://doi.org/10.1080/1744666X.2026.2625967

Chicago Style (17th ed.) Citation

JSY, Mah, Eng PC, Izzi-Engbeaya C, and Finney LJ. "The Role of Glucagon-like Peptide-1 Receptor Agonists and Sodium-glucose Cotransporter-2 Inhibitors in Chronic Obstructive Pulmonary Disease." Expert Review of Clinical Immunology 22, no. 1 (2026): 31. https://doi.org/10.1080/1744666X.2026.2625967.

MLA (9th ed.) Citation

JSY, Mah, et al. "The Role of Glucagon-like Peptide-1 Receptor Agonists and Sodium-glucose Cotransporter-2 Inhibitors in Chronic Obstructive Pulmonary Disease." Expert Review of Clinical Immunology, vol. 22, no. 1, 2026, p. 31, https://doi.org/10.1080/1744666X.2026.2625967.